Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey.
Duke University School of Medicine, Durham, North Carolina.
Surg Obes Relat Dis. 2021 Nov;17(11):1919-1925. doi: 10.1016/j.soard.2021.07.023. Epub 2021 Aug 5.
Gastroesophageal reflux disease (GERD) is a common disease in patients with obesity. The incidence of de novo GERD and the effect of bariatric surgery on patients with pre-existing GERD remain controversial. Management of GERD following bariatric surgery is complicated and can range from medical therapy to non-invasive endoscopic options to invasive surgical options. To address these issues, we performed a systematic review of the literature on the incidence of GERD and the various modalities of managing GERD in patients following bariatric surgery. Given the increased number of laparoscopic sleeve gastrectomy (LSG) procedures being performed and the high incidence of GERD following LSG, bariatric surgeons should be familiar with the options available to manage GERD following LSG as well as other bariatric procedures.
胃食管反流病（GERD）是肥胖患者的常见疾病。新发性 GERD 的发病率和减重手术对已有 GERD 患者的影响仍存在争议。减重手术后 GERD 的管理较为复杂，可包括药物治疗、非侵入性内镜治疗和侵入性手术治疗。为了解决这些问题，我们对减重手术后 GERD 的发病率以及各种治疗方法进行了系统的文献回顾。鉴于腹腔镜袖状胃切除术（LSG）数量的增加以及 LSG 后 GERD 的高发病率，减重外科医生应该熟悉 LSG 及其他减重手术后治疗 GERD 的各种方法。
